Financhill
Back

Xeris Biopharma Holdings, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
72

XERS
Xeris Biopharma Holdings, Inc.

Last Price:
$7.22
Seasonality Move:
-6.43%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight selling pressure.

Xeris Biopharma Holdings, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 7.11 Buy
20-day SMA: 6.99 Buy
50-day SMA: 7.88 Sell
200-day SMA: 6.26 Buy
8-day EMA: 4.54 Buy
20-day EMA: 2.36 Buy
50-day EMA: 1.06 Buy
200-day EMA: 0.28 Buy

Xeris Biopharma Holdings, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.59 Buy
Relative Strength Index (14 RSI): 49.45 Sell
Chaikin Money Flow: -556944 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.78 - 7.2) Buy
Bollinger Bands (100): (6.78 - 8.68) Sell

Xeris Biopharma Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Xeris Biopharma Holdings, Inc. Stock

Is Xeris Biopharma Holdings, Inc. Stock a Buy?

XERS Technical Analysis vs Fundamental Analysis

Buy
72
Xeris Biopharma Holdings, Inc. (XERS) is a Buy

Is Xeris Biopharma Holdings, Inc. a Buy or a Sell?

Xeris Biopharma Holdings, Inc. Stock Info

Market Cap:
1.2B
Price in USD:
7.21
Share Volume:
1.4M

Xeris Biopharma Holdings, Inc. 52-Week Range

52-Week High:
10.08
52-Week Low:
3.14
Buy
72
Xeris Biopharma Holdings, Inc. (XERS) is a Buy

Xeris Biopharma Holdings, Inc. Share Price Forecast

Is Xeris Biopharma Holdings, Inc. Stock a Buy?

Fundamental Analysis of Xeris Biopharma Holdings, Inc.

Is Xeris Biopharma Holdings, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.25 per share.

Technical Analysis of Xeris Biopharma Holdings, Inc.

Should I short Xeris Biopharma Holdings, Inc. stock?

* Xeris Biopharma Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.